Search research articles
Contact Us
Filters
Showing results (171-180 of 768) with videos related to
Page
of 77
Sort By:
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|
September 22, 2009
Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design
Melissa A Friedman, Mercedes Fernandez, Jeffrey S Wefel, et al.
Leukemia & Lymphoma
|
October 26, 2011
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines
Benigno C Valdez, David Murray, Yago Nieto, et al.
The American Journal of Medicine
|
March 30, 1984
Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial
D J Winston, W G Ho, C H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission
G J Schiller, S D Nimer, M C Territo, et al.
Leukemia & Lymphoma
|
October 23, 2013
The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan
Guiyun Song, Benigno C Valdez, Yang Li, et al.
Bone Marrow Transplantation
|
July 3, 2007
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
E Jabbour, G Rondon, P Anderlini, et al.
Cancer
|
January 11, 2005
The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation
Amar Safdar, Gilhen Rodriguez, Norio Ohmagari, et al.
Statistics in Medicine
|
February 15, 2003
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes
Peter F Thall, J Kyle Wathen, B Nebiyou Bekele, et al.
Plos One
|
March 8, 2013
Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials
Bipulendu Jena, Sourindra Maiti, Helen Huls, et al.
The American Journal of Medicine
|
September 1, 1984
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients
D J Winston, R C Barnes, W G Ho, et al.
Page
of 77
Search research articles
Search
Showing results (171-180 of 768) with videos related to
Sort By:
Page
of 77
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|
September 22, 2009
Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design
Melissa A Friedman, Mercedes Fernandez, Jeffrey S Wefel, et al.
Leukemia & Lymphoma
|
October 26, 2011
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines
Benigno C Valdez, David Murray, Yago Nieto, et al.
The American Journal of Medicine
|
March 30, 1984
Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial
D J Winston, W G Ho, C H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission
G J Schiller, S D Nimer, M C Territo, et al.
Leukemia & Lymphoma
|
October 23, 2013
The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan
Guiyun Song, Benigno C Valdez, Yang Li, et al.
Bone Marrow Transplantation
|
July 3, 2007
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
E Jabbour, G Rondon, P Anderlini, et al.
Cancer
|
January 11, 2005
The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation
Amar Safdar, Gilhen Rodriguez, Norio Ohmagari, et al.
Statistics in Medicine
|
February 15, 2003
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes
Peter F Thall, J Kyle Wathen, B Nebiyou Bekele, et al.
Plos One
|
March 8, 2013
Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials
Bipulendu Jena, Sourindra Maiti, Helen Huls, et al.
The American Journal of Medicine
|
September 1, 1984
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients
D J Winston, R C Barnes, W G Ho, et al.
Page
of 77